When the ACA passed in 2010, the Cadillac tax, a nondeductible 40 percent excise tax imposed on the portion of health coverage costs that exceeds $10,200 for single coverage and $27,500 for family coverage, was scheduled to take effect in 2018. It has since been delayed twice and is currently scheduled to take effect in 2022. The Cadillac tax is controversial. It is the first time that the historically unlimited tax exclusion for employment-based health benefits has been impacted. Although it has its enthusiasts, there has been bipartisan support for repealing it. The Joint Tax Committee (JCT) and Congressional Budget Office (CBO) assume that when employers reduce the comprehensiveness of health benefits to avoid the tax that they will in turn increase worker taxable wages such that total compensation is unchanged. This webinar will focus on this aspect of the Cadillac tax.
When: Friday, March 1 at 2:00 p.m. EST
- Paul Fronstin, Director of Health Research, EBRI
- Heather Meade, Principal, Ernst & Young
- Michael Chernew, Ph.D., Leonard D. Schaeffer Professor of Health Care Policy and the Director of the Healthcare Markets and Regulation (HMR) Lab in the Department of Health Care Policy, Harvard Medical School.